{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:18:22Z","timestamp":1791919102925,"version":"4.3.4"},"reference-count":139,"publisher":"MDPI AG","issue":"24","license":[{"start":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T00:00:00Z","timestamp":1671408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Funding for Centers of Excellence"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Coumarin is an effective treatment for primary lymphoedema, as well as lymphoedema related to breast cancer radiotherapy or surgery. However, its clinical use is limited in several countries due to the possible occurrence of hepatotoxicity, mainly in the form of mild to moderate transaminase elevation. It is worth noting that only a few cases of severe hepatotoxicity have been described in the literature, with no reported cases of liver failure. Data available on coumarin absorption, distribution, metabolism, and excretion have been reviewed, focusing on hepatotoxicity studies carried out in vitro and in vivo. Finally, safety and tolerability data from clinical trials have been thoroughly discussed. Based on these data, coumarin-induced hepatotoxicity is restricted to a small subset of patients, probably due to the activation in these individuals of alternative metabolic pathways involving specific CYP450s isoforms. The aim of this work is to stimulate research to clearly identify patients at risk of developing hepatotoxicity following coumarin treatment. Early identification of this subset of patients could open the possibility of more safely exploiting the therapeutical properties of coumarin, allowing patients suffering from lymphoedema to benefit from the anti-oedematous activity of the treatment.<\/jats:p>","DOI":"10.3390\/molecules27249063","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T09:05:09Z","timestamp":1671440709000},"page":"9063","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":60,"title":["Coumarin-Induced Hepatotoxicity: A Narrative Review"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7168-3353","authenticated-orcid":false,"given":"Michele","family":"Pitaro","sequence":"first","affiliation":[{"name":"INBB\u2014Biostructures and Biosystems National Institute, Viale delle Medaglie d\u2019Oro 305, 00136 Rome, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Croce","sequence":"additional","affiliation":[{"name":"INBB\u2014Biostructures and Biosystems National Institute, Viale delle Medaglie d\u2019Oro 305, 00136 Rome, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Gallo","sequence":"additional","affiliation":[{"name":"Department of Science, Roma Tre University, Viale Guglielmo Marconi 446, 00146 Rome, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyexandra","family":"Arienzo","sequence":"additional","affiliation":[{"name":"INBB\u2014Biostructures and Biosystems National Institute, Viale delle Medaglie d\u2019Oro 305, 00136 Rome, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8304-9042","authenticated-orcid":false,"given":"Giulia","family":"Salvatore","sequence":"additional","affiliation":[{"name":"INBB\u2014Biostructures and Biosystems National Institute, Viale delle Medaglie d\u2019Oro 305, 00136 Rome, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2115-8961","authenticated-orcid":false,"given":"Giovanni","family":"Antonini","sequence":"additional","affiliation":[{"name":"INBB\u2014Biostructures and Biosystems National Institute, Viale delle Medaglie d\u2019Oro 305, 00136 Rome, RM, Italy"},{"name":"Department of Science, Roma Tre University, Viale Guglielmo Marconi 446, 00146 Rome, RM, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,12,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1161\/01.CIR.89.1.432","article-title":"History of Drugs for Thrombotic Disease. Discovery, Development, and Directions for the Future","volume":"89","author":"Mueller","year":"1994","journal-title":"Circulation"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/01.CIR.19.1.97","article-title":"The Discovery of Dicumarol and Its Sequels","volume":"19","author":"Link","year":"1959","journal-title":"Circulation"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/hrt.66.2.181","article-title":"Dicoumarol and Warfarin","volume":"66","author":"Hollman","year":"1991","journal-title":"Heart"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.funbio.2010.12.009","article-title":"Coumarin Metabolic Routes in Aspergillus Spp.","volume":"115","author":"Orden","year":"2011","journal-title":"Fungal Biol."},{"key":"ref_5","first-page":"2599","article-title":"Metabolism of Vitamin K and Prothrombin Synthesis: Anticoagulants and the Vitamin K--Epoxide Cycle","volume":"37","author":"Bell","year":"1978","journal-title":"Fed. Proc."},{"key":"ref_6","unstructured":"Bowden, M.E., Crow, A.B., and Sullivan, T. (2003). Pharmaceutical Achievers: The Human Face of Pharmaceutical Research, Chemical Heritage Foundation."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/toxsci\/66.1.4","article-title":"The Missing Link: The Story of Karl Paul Link","volume":"66","author":"Last","year":"2002","journal-title":"Toxicol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1055\/s-2007-996418","article-title":"Pharmacology of Warfarin and Clinical Implications","volume":"25","author":"Keller","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_9","first-page":"1","article-title":"Warfarin: From Rat Poison to Clinical Use","volume":"Milestone 2","author":"Lim","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Elango, K., Javaid, A., Khetarpal, B.K., Ramalingam, S., Kolandaivel, K.P., Gunasekaran, K., and Ahsan, C. (2021). The Effects of Warfarin and Direct Oral Anticoagulants on Systemic Vascular Calcification: A Review. Cells, 10.","DOI":"10.3390\/cells10040773"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dewick, P.M. (2001). Medicinal Natural Products, John Wiley & Sons, Ltd.","DOI":"10.1002\/0470846275"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"124","DOI":"10.2174\/1568026618666180329115523","article-title":"Coumarin Compounds in Medicinal Chemistry: Some Important Examples from the Last Years","volume":"18","author":"Pereira","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"963248","DOI":"10.1155\/2013\/963248","article-title":"Review on Natural Coumarin Lead Compounds for Their Pharmacological Activity","volume":"2013","author":"Venugopala","year":"2013","journal-title":"BioMed. Res. Int."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Rao, A.V., and Rao, L.G. (2015). Coumarins\u2014An Important Class of Phytochemicals. Phytochemicals-Isolation, Characterisation and Role in Human Health, InTechOpen.","DOI":"10.5772\/58648"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Murray, R.D.H. (1997). Naturally Occurring Plant Coumarins. Fortschritte der Chemie Organischer Naturstoffe\/Progress in the Chemistry of Organic Natural Products, Springer Vienna.","DOI":"10.1007\/978-3-7091-6527-0_1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1089\/act.2009.15104","article-title":"Plant Coumarins: Myths and Realities","volume":"15","author":"Yarnell","year":"2009","journal-title":"Altern. Complement. Ther."},{"key":"ref_17","unstructured":"Keating, G., and O\u2019kennedy, R. (1997). The Chemistry and Occurrence of Coumarins. Coumarins: Biology, Applications and Mode of Action, Wiley."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1590\/S0103-50532007000200030","article-title":"A SARS-Coronovirus 3CL Protease Inhibitor Isolated from the Marine Sponge Axinella Cf. Corrugata: Structure Elucidation and Synthesis","volume":"18","author":"Lira","year":"2007","journal-title":"J. Braz. Chem. Soc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3884","DOI":"10.2174\/1381612811319210013","article-title":"Current Developments of Coumarin Compounds in Medicinal Chemistry","volume":"19","author":"Peng","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Annunziata, F., Pinna, C., Dallavalle, S., Tamborini, L., and Pinto, A. (2020). An Overview of Coumarin as a Versatile and Readily Accessible Scaffold with Broad-Ranging Biological Activities. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21134618"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0378-8741(99)00165-8","article-title":"Antinociceptive, Anti-Inflammatory and Bronchodilator Activities of Brazilian Medicinal Plants Containing Coumarin: A Comparative Study","volume":"70","author":"Leal","year":"2000","journal-title":"J. Ethnopharmacol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2217\/17469600.1.3.315","article-title":"Biologically Active Coumarins as Inhibitors of HIV-1","volume":"1","author":"Kostova","year":"2007","journal-title":"Futur. HIV Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"517S","DOI":"10.1093\/ajcn\/78.3.517S","article-title":"Health Benefits of Fruit and Vegetables Are from Additive and Synergistic Combinations of Phytochemicals","volume":"78","author":"Liu","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Singh, J., and Yadav, A.N. (2020). Natural Products as Fungicide and Their Role in Crop Protection. Natural Bioactive Products in Sustainable Agriculture, Springer Singapore.","DOI":"10.1007\/978-981-15-3024-1"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/ptr.875","article-title":"Effects of Melilotus Officinalis on Acute Inflammation","volume":"16","author":"Buia","year":"2002","journal-title":"Phytother. Res."},{"key":"ref_26","first-page":"1142","article-title":"Antioxidant Activity, Phenol and Flavonoid Contents of Some Selected Iranian Medicinal Plants","volume":"5","author":"Pourmorad","year":"2006","journal-title":"Afr. J. Biotechnol."},{"key":"ref_27","first-page":"903","article-title":"Evaluation of Hepatoprotective Activity of Melilotus Officinalis L. Against Paracetamol and Carbon Tetrachloride Induced Hepatic Injury in Mice","volume":"74","author":"Alamgeer","year":"2017","journal-title":"Acta Pol. Pharm."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"396","DOI":"10.22159\/ajpcr.2017.v10i6.17183","article-title":"Evaluation of Anxiolytic Effect of Melilotus Officinalis Extracts in Mice","volume":"10","author":"Kaur","year":"2017","journal-title":"Asian J. Pharm. Clin. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0308-8146(02)00282-0","article-title":"Antioxidant, Anti-Inflammatory and Antiproliferative Properties of Sixteen Water Plant Extracts Used in the Limousin Countryside as Herbal Teas","volume":"80","author":"Trouillas","year":"2003","journal-title":"Food Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2174\/138161210790112737","article-title":"Pharmacogenetics of Oral Anticoagulant Therapy","volume":"16","author":"Schalekamp","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0037-1615385","article-title":"Warfarin or Acenocoumarol: Which Is Better in the Management of Oral Anticoagulants?","volume":"80","author":"Barcellona","year":"1998","journal-title":"J. Thromb. Haemost."},{"key":"ref_32","first-page":"860","article-title":"Further Evidence for the Induction of Proteolysis by Coumarin in Rats with Various High-Protein Oedemas","volume":"27","author":"Piller","year":"1977","journal-title":"Arzneimittelforschung"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF00292302","article-title":"Conservative Therapy for Postmastectomy Lymphedema","volume":"4","author":"Clodius","year":"1978","journal-title":"Chir. Plastica."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/lrb.2017.0020","article-title":"Strategies for Avoiding Benzopyrone Hepatotoxicity in Lymphedema Management\u2014The Role of Pharmacogenetics, Metabolic Enzyme Gene Identification, and Patient Selection","volume":"15","author":"Hu","year":"2017","journal-title":"Lymphat. Res. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/lrb.2005.3.81","article-title":"Pharmacogenomics: Its Role in Re-Establishing Coumarin as Treatment for Lymphedema","volume":"3","author":"Farinola","year":"2005","journal-title":"Lymphat. Res. Biol."},{"key":"ref_36","unstructured":"Casley-Smith, J.R., and Casley-Smith, J.R. (1997). Coumarin in the Treatment of Lymphoedema and Other High-Protein Oedemas. Coumarins: Biology, Applications and Mode of Action, John Wiley & Sons, Inc."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.1007\/BF01377124","article-title":"An Updated Review of the Clinical Development of Coumarin (1,2-Benzopyrone) and 7-Hydroxycoumarin","volume":"120","author":"Marshall","year":"1994","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.2174\/092986708786242877","article-title":"A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer","volume":"15","author":"Musa","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1039\/C4TC02665A","article-title":"\u03c0-Expanded Coumarins: Synthesis, Optical Properties and Applications","volume":"3","author":"Tasior","year":"2015","journal-title":"J. Mater. Chem. C"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jff.2019.04.008","article-title":"Sustainable Production of Natural Phenolics for Functional Food Applications","volume":"57","author":"Mark","year":"2019","journal-title":"J. Funct. Foods"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1007\/s00044-015-1350-8","article-title":"Recent Advances and Therapeutic Journey of Coumarins: Current Status and Perspectives","volume":"24","author":"Barot","year":"2015","journal-title":"Med. Chem. Res."},{"key":"ref_42","first-page":"348","article-title":"Toxicity of Coumarin","volume":"118","author":"Hazleton","year":"1956","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0278-6915(99)00010-1","article-title":"Coumarin Metabolism, Toxicity and Carcinogenicity: Relevance for Human Risk Assessment","volume":"37","author":"Lake","year":"1999","journal-title":"Food Chem. Toxicol."},{"key":"ref_44","unstructured":"Swenberg, J. (2003). Covalent Binding Index Study on Coumarin, Report of Laboratory of Molecular Carcinogenesis and Mutagenesis, University of North Carolina. Submitted by European Flavour and Fragrance Association (EFFA), Square Marie-Louise."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0278-6915(98)00025-8","article-title":"Lack of Effect of Coumarin on Unscheduled DNA Synthesis in Precision-Cut Human Liver Slices","volume":"36","author":"Beamand","year":"1998","journal-title":"Food Chem. Toxicol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0015-6264(67)82961-4","article-title":"Food Flavourings and Compounds of Related Structure. II. Subacute and Chronic Toxicity","volume":"5","author":"Hagan","year":"1967","journal-title":"Food Cosmet. Toxicol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/mnfr.200900281","article-title":"Toxicology and Risk Assessment of Coumarin: Focus on Human Data","volume":"54","author":"Abraham","year":"2010","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"e698","DOI":"10.1161\/CIRCULATIONAHA.105.603100","article-title":"Anticoagulants and Transaminase Elevation","volume":"113","author":"Arora","year":"2006","journal-title":"Circulation"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jhep.2004.03.010","article-title":"Phenprocoumon-Induced Liver Disease Ranges from Mild Acute Hepatitis to (Sub-) Acute Liver Failure","volume":"41","author":"Schimanski","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3109\/03602539008991449","article-title":"The Pharmacology, Metabolism, Analysis, and Applications of Coumarin and Coumarin-Related Compounds","volume":"22","author":"Egan","year":"1990","journal-title":"Drug Metab. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/1091581819884544","article-title":"Cancer Hazard Identification Integrating Human Variability: The Case of Coumarin","volume":"38","author":"Hsieh","year":"2019","journal-title":"Int. J. Toxicol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"109401","DOI":"10.1016\/j.biopha.2019.109401","article-title":"Effects of Imperatorin in the Cardiovascular System and Cancer","volume":"120","author":"Nasser","year":"2019","journal-title":"Biomed Pharm."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1701073","DOI":"10.1002\/mnfr.201701073","article-title":"Pharmacological and Nutritional Effects of Natural Coumarins and Their Structure-Activity Relationships","volume":"62","author":"Zhu","year":"2018","journal-title":"Mol. Nutr. Food Res."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.2174\/0929867324666170502122740","article-title":"In Vitro and In Vivo Experimental Model-Based Approaches for Investigating Anti-Inflammatory Properties of Coumarins","volume":"25","author":"Frode","year":"2018","journal-title":"Curr. Med. Chem."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.2174\/1568026615666150220112437","article-title":"Cardiovascular Effects of Coumarins besides Their Antioxidant Activity","volume":"15","author":"Najmanova","year":"2015","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"110522","DOI":"10.1016\/j.fct.2019.05.030","article-title":"RIFM Fragrance Ingredient Safety Assessment, Coumarin, CAS Registry Number 91-64-5","volume":"130","author":"Api","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"803338","DOI":"10.3389\/fphar.2022.803338","article-title":"Safety Profile of Nutraceuticals Rich in Coumarins: An Update","volume":"13","author":"Heghes","year":"2022","journal-title":"Front. Pharm."},{"key":"ref_58","first-page":"11795514211042024","article-title":"A Review of Coumarins and Coumarin-Related Compounds for Their Potential Antidiabetic Effect","volume":"14","author":"Bipat","year":"2021","journal-title":"Clin. Med. Insights Endocrinol. Diabetes"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Foroozesh, M., Sridhar, J., Goyal, N., and Liu, J. (2019). Coumarins and P450s, Studies Reported to-Date. Molecules, 24.","DOI":"10.3390\/molecules24081620"},{"key":"ref_60","first-page":"99","article-title":"First-Pass Effect of Coumarin in Man","volume":"17","author":"Ritschel","year":"1979","journal-title":"Int. J. Clin. Pharmacol. Biopharm."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0278-6915(00)00123-X","article-title":"The in Vivo Dermal Absorption and Metabolism of [4-14C] Coumarin by Rats and by Human Volunteers under Simulated Conditions of Use in Fragrances","volume":"39","author":"Ford","year":"2001","journal-title":"Food Chem. Toxicol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00561066","article-title":"Pharmacokinetics of Coumarin and Its 7-Hydroxy-Metabolites upon Intravenous and Peroral Administration of Coumarin in Man","volume":"12","author":"Ritschel","year":"1977","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_63","first-page":"1254","article-title":"Pharmacokinetics of Coumarin, 7-Hydroxycoumarin and 7-Hydroxycoumarin Glucuronide in the Blood and Brain of Gerbils Following Intraperitoneal Administration of Coumarin","volume":"33","author":"Ritschel","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1021\/bi00436a007","article-title":"Mouse Steroid 15.Alpha.-Hydroxylase Gene Family: Identification of Type II P-45015.Alpha. as Coumarin 7-Hydroxylase","volume":"28","author":"Negishi","year":"1989","journal-title":"Biochemistry"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0003-9861(92)90115-D","article-title":"Species Differences and Interindividual Variation in Liver Microsomal Cytochrome P450 2A Enzymes: Effects on Coumarin, Dicumarol, and Testosterone Oxidation","volume":"298","author":"Pearce","year":"1992","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"3889","DOI":"10.1016\/0006-2952(88)90070-6","article-title":"Immunochemical and Catalytical Studies on Hepatic Coumarin 7-Hydroxylase in Man, Rat, and Mouse","volume":"37","author":"Raunio","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/toxsci\/kfh237","article-title":"Roles for Epoxidation and Detoxification of Coumarin in Determining Species Differences in Clara Cell Toxicity","volume":"82","author":"Vassallo","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.tiv.2005.08.001","article-title":"Metabolism of Coumarin by Human P450s: A Molecular Modelling Study","volume":"20","author":"Lewis","year":"2006","journal-title":"Toxicol. Vitr."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Leonart, L., Gasparetto, J., Pontes, F., Cerqueira, L., de Francisco, T., and Pontarolo, R. (2017). New Metabolites of Coumarin Detected in Human Urine Using Ultra Performance Liquid Chromatography\/Quadrupole-Time-of-Flight Tandem Mass Spectrometry. Molecules, 22.","DOI":"10.3390\/molecules22112031"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0742-8413(93)90102-Q","article-title":"Species Differences in the Metabolism and Hepatotoxicity of Coumarin","volume":"104","author":"Fentem","year":"1993","journal-title":"Comp. Biochem. Physiol. C Comp. Pharmacol. Toxicol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/faat.1996.0181","article-title":"Comparison of the Hepatotoxicity of Coumarin in the Rat, Mouse, and Syrian Hamster: A Dose and Time Response Study","volume":"34","author":"Lake","year":"1996","journal-title":"Fundam. Appl. Toxicol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0378-4347(92)80166-N","article-title":"Comparison of a Novel Thin-Layer Chromatographic-Fluorescence Detection Method with a Spectrofluorometric Method for the Determination of 7-Hydroxycoumarin in Human Urine","volume":"575","author":"Cholerton","year":"1992","journal-title":"J. Chromatogr."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00008571-199210000-00005","article-title":"Interindividual Variability of Coumarin 7-Hydroxylation in Healthy Volunteers","volume":"2","author":"Rautio","year":"1992","journal-title":"Pharmacogenetics"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/221664b0","article-title":"Metabolism of Coumarin in Man","volume":"221","author":"Shilling","year":"1969","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1021\/jm50014a002","article-title":"The Metabolism of [3- 14 C] Coumarin","volume":"3","author":"Kaighen","year":"1961","journal-title":"J. Med. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3109\/00498259409043288","article-title":"Metabolism of Coumarin and 7-Ethoxycoumarin by Rat, Mouse, Guinea Pig, Cynomolgus Monkey and Human Precision-Cut Liver Slices","volume":"24","author":"Steensma","year":"1994","journal-title":"Xenobiotica"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0015-6264(79)90289-X","article-title":"Critical Review of the Toxicology of Coumarin with Special Reference to Interspecies Differences in Metabolism and Hepatotoxic Response and Their Significance to Man","volume":"17","author":"Cohen","year":"1979","journal-title":"Food Cosmet. Toxicol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5694\/j.1326-5377.1994.tb126942.x","article-title":"Possible Coumarin Hepatotoxicity","volume":"161","author":"Beinssen","year":"1994","journal-title":"Med. J. Aust."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"391","DOI":"10.5694\/j.1326-5377.1995.tb139958.x","article-title":"Frequency of Coumarin Hepatotoxicity","volume":"162","year":"1995","journal-title":"Med. J. Aust."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1136\/pgmj.71.841.701-a","article-title":"Side-Effects of Coumarin","volume":"71","author":"Morrison","year":"1995","journal-title":"Postgrad. Med. J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5694\/j.1326-5377.1995.tb126130.x","article-title":"Liver Failure While Taking Coumarin","volume":"163","author":"Bassett","year":"1995","journal-title":"Med. J. Aust."},{"key":"ref_82","first-page":"223","article-title":"Acute cytolytic hepatitis caused by coumarin. 2 cases","volume":"21","author":"Koch","year":"1997","journal-title":"Gastroenterol. Clin. Biol."},{"key":"ref_83","first-page":"651","article-title":"A Genetic Polymorphism in Coumarin 7-Hydroxylation: Sequence of the Human CYP2A Genes and Identification of Variant CYP2A6 Alleles","volume":"57","author":"Hoffman","year":"1995","journal-title":"Am. J. Hum. Genet."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s002280050489","article-title":"Variability of Coumarin 7- and 3-Hydroxylation in a Jordanian Population Is Suggestive of a Functional Polymorphism in Cytochrome P450 CYP2A6","volume":"54","author":"Hadidi","year":"1998","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0014-5793(98)01297-6","article-title":"Genotyping of Human Cytochrome P450 2A6 (CYP2A6), a Nicotine C -Oxidase","volume":"438","author":"Oscarson","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0278-6915(97)00066-5","article-title":"A Single Amino Acid Substitution (Leu160His) in Cytochrome P450 CYP2A6 Causes Switching from 7-Hydroxylation to 3-Hydroxylation of Coumarin","volume":"35","author":"Hadidi","year":"1997","journal-title":"Food Chem. Toxicol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2217\/14622416.8.2.151","article-title":"CYP2A6 Polymorphisms: Is There a Role for Pharmacogenomics in Preventing Coumarin-Induced Hepatotoxicity in Lymphedema Patients?","volume":"8","author":"Farinola","year":"2007","journal-title":"Pharmacogenomics"},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Kato, K., Nakayoshi, T., Nokura, R., Hosono, H., Hiratsuka, M., Ishikawa, Y., Kurimoto, E., and Oda, A. (2021). Deciphering Structural Alterations Associated with Activity Reductions of Genetic Polymorphisms in Cytochrome P450 2A6 Using Molecular Dynamics Simulations. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms221810119"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3109\/00498259409043279","article-title":"Metabolism of [3- 14 C] Coumarin by Human Liver Microsomes","volume":"24","author":"Henderson","year":"1994","journal-title":"Xenobiotica"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"141","DOI":"10.5414\/CPP41141","article-title":"Single Copy of Variant CYP2A6 Alleles Does Not Confer Susceptibility to Liver Dysfunction in Patients Treated with Coumarin","volume":"41","author":"Burian","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.tiv.2008.09.004","article-title":"Differences in Simulated Liver Concentrations of Toxic Coumarin Metabolites in Rats and Different Human Populations Evaluated through Physiologically Based Biokinetic (PBBK) Modeling","volume":"22","author":"Rietjens","year":"2008","journal-title":"Toxicol. Vitr."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1124\/dmd.116.073494","article-title":"Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C -Oxidation and Coumarin 7-Hydroxylation Activities","volume":"45","author":"Hosono","year":"2017","journal-title":"Drug Metab. Dispos."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0041-008X(89)90336-0","article-title":"Studies on the Mechanism of Coumarin-Induced Toxicity in Rat Hepatocytes: Comparison with Dihydrocoumarin and Other Coumarin Metabolites","volume":"97","author":"Lake","year":"1989","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0278-6915(09)80007-0","article-title":"Comparison of the Hepatic Effects of Coumarin, 3,4-Dimethylcoumarin, Dihydrocoumarin and 6-Methylcoumarin in the Rat","volume":"32","author":"Lake","year":"1994","journal-title":"Food Chem. Toxicol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/toxsci\/58.1.23","article-title":"In Vitro Kinetics of Coumarin 3,4-Epoxidation: Application to Species Differences in Toxicity and Carcinogenicity","volume":"58","author":"Born","year":"2000","journal-title":"Toxicol. Sci."},{"key":"ref_96","first-page":"218","article-title":"O-Hydroxyphenylacetaldehyde Is a Hepatotoxic Metabolite of Coumarin","volume":"28","author":"Born","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0006-291X(91)91354-F","article-title":"O-Hydroxyphenylacetaldehyde: A Major Novel Metabolite of Coumarin Formed by Rat, Gerbil and Human Liver Microsomes","volume":"179","author":"Fentem","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0278-6915(92)90145-B","article-title":"Metabolism of [3-14C] Coumarin to Polar and Covalently Bound Products by Hepatic Microsomes from the Rat, Syrian Hamster, Gerbil and Humans","volume":"30","author":"Lake","year":"1992","journal-title":"Food Chem. Toxicol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/toxsci\/kfh162","article-title":"Metabolic Detoxification Determines Species Differences in Coumarin-Induced Hepatotoxicity","volume":"80","author":"Vassallo","year":"2004","journal-title":"Toxicol. Sci."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/00034983.1989.11812346","article-title":"The Effects of 5,6 Benzo-[a]-Pyrone (Coumarin) and DEC on Filaritic Lymphoedema and Elephantiasis in India. Preliminary Results","volume":"83","author":"Jamal","year":"1989","journal-title":"Ann. Trop. Med. Parasitol."},{"key":"ref_101","first-page":"767","article-title":"Coumarin in Melanoma Patients: An Experimental and Clinical Study","volume":"10","author":"Lange","year":"1984","journal-title":"Drugs Exp. Clin. Res."},{"key":"ref_102","first-page":"431","article-title":"Prevention of Early Recurrence of High Risk Malignant Melanoma by Coumarin. Irish Melanoma Group","volume":"15","author":"Thornes","year":"1989","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1177\/096032718900800612","article-title":"The Rarity of Liver Toxicity in Patients Treated with Coumarin (1, 2-Benzopyrone)","volume":"8","author":"Cox","year":"1989","journal-title":"Hum. Toxicol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JCO.1990.8.2.325","article-title":"Phase II Study of Coumarin and Cimetidine in Patients with Metastatic Renal Cell Carcinoma","volume":"8","author":"Dexeus","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"ref_105","first-page":"91","article-title":"Treatment of Non-Small Cell Lung Cancer with Coumarin and Cimetidine 1, 2","volume":"71","author":"Marshall","year":"1987","journal-title":"Cancer Treat. Rep."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00254109","article-title":"Treatment of Advanced Malignant Melanoma with Coumarin and Cimetidine: A Pilot Study","volume":"24","author":"Marshall","year":"1989","journal-title":"Cancer Chemother. Pharm."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000157921","article-title":"The Treatment of Experimental Lymphedema","volume":"9","year":"1972","journal-title":"J. Vasc. Res."},{"key":"ref_108","unstructured":"von Sachverst Bergmann, K. (1999). Andigengutachten Zur Beurteilung von Cumarin in Arzneimitteln in Bezug Auf Lebertoxische Wirkung Beim Menschen (Expert Report for the Evaluation of Coumarin in Medicinal Products with Regard to Hepatotoxicity in Humans), Rheinische Friedrich-Wilhelms-Universit\u00e4t. Available online: https:\/\/www.bfarm.de\/EN\/Home\/_node.html."},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"European Food Safety Authority (EFSA) (2004). Opinion of the Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC) Related to Coumarin. EFSA J., 2, 104.","DOI":"10.2903\/j.efsa.2004.104"},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/(SICI)1099-1557(199808)7:1+<S45::AID-PDS353>3.0.CO;2-1","article-title":"French Pharmacovigilance Survey Evaluating the Hepatic Toxicity of Coumarin","volume":"7","author":"Gersberg","year":"1998","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1200\/JCO.1987.5.6.862","article-title":"Treatment of Metastatic Renal Cell Carcinoma with Coumarin (1,2-Benzopyrone) and Cimetidine: A Pilot Study","volume":"5","author":"Marshall","year":"1987","journal-title":"J. Clin. Oncol."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/pros.2990200208","article-title":"Phase II Evaluation of Coumarin (1,2-Benzopyrone) in Metastatic Prostatic Carcinoma","volume":"20","author":"Mohler","year":"1992","journal-title":"Prostate"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1056\/NEJM199310143291604","article-title":"Treatment of Lymphedema of the Arms and Legs with 5,6-Benzo-[Alpha]-Pyrone","volume":"329","author":"Morgan","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.307.6911.1037","article-title":"Treatment of Filarial Lymphoedema and Elephantiasis with 5,6-Benzo-Alpha-Pyrone (Coumarin)","volume":"307","author":"Wang","year":"1993","journal-title":"BMJ"},{"key":"ref_115","first-page":"3","article-title":"Comparative Study of the Clinical Efficacy of Two Different Coumarin Dosages in the Management of Arm Lymphedema after Treatment for Breast Cancer","volume":"32","author":"Burgos","year":"1999","journal-title":"Lymphology"},{"key":"ref_116","first-page":"449","article-title":"Combined Treatment of Advanced Malignant Melanoma with Coumarin and Cimetidine","volume":"7","author":"Nolte","year":"1987","journal-title":"Anticancer Res."},{"key":"ref_117","first-page":"91","article-title":"Synthesis of Novel Coumarin 3-(N-Aryl)-Sulfonamides & Evaluated for Their Anti-Cancer Activity and Reported in Vitro Inhibitory Activity on Human Platelet Aggregation","volume":"48","author":"Kokron","year":"1991","journal-title":"Oncology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1054\/bjom.2000.0459","article-title":"Prophylaxis of Radiogenic Sialadenitis and Mucositis by Coumarin\/Troxerutine in Patients with Head and Neck Cancer\u2014A Prospective, Randomized, Placebo-Controlled, Double-Blind Study","volume":"39","author":"Kohnen","year":"2001","journal-title":"Br. J. Oral Maxillofac. Surg."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1024\/0301-1526.31.3.185","article-title":"Wirksamkeit und Sicherheit einer Cumarin-\/Troxerutin-Kombination (SB-LOT) bei Patienten mit chronischer ven\u00f6ser Insuffizienz: Eine doppelblinde, placebo-kontrollierte, randomisierte klinische Studie","volume":"31","author":"Vanscheidt","year":"2002","journal-title":"Vasa"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5414\/CPP41193","article-title":"Safety Aspects of a Coumarin-Troxerutin Combination Regarding Liver Function in a Double-Blind Placebo-Controlled Study","volume":"41","author":"Becker","year":"2003","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"ref_121","first-page":"805\u2014812","article-title":"Lymphatic Edema of the Lower Limbs after Orthopedic Surgery: Results of a Randomized, Open-Label Clinical Trial with a New Extended-Release Preparation","volume":"29","author":"Lessiani","year":"2015","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1056\/NEJM199902043400503","article-title":"Lack of Effect of Coumarin in Women with Lymphedema after Treatment for Breast Cancer","volume":"340","author":"Loprinzi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_123","first-page":"106","article-title":"The Use of 5, 6 Benzo-[\u03b1]-Pyrone (Coumarin) and Heating by Microwaves in the Treatment of Chronic Lymphedema of the Legs","volume":"29","author":"Chang","year":"1996","journal-title":"Lymphology"},{"key":"ref_124","doi-asserted-by":"crossref","unstructured":"De Silva, D.A.M., Jeewanthi, R.K.C., Rajapaksha, R.H.N., Weddagala, W.M.T.B., Hirotsu, N., Shimizu, B., and Munasinghe, M.A.J.P. (2021). Clean vs Dirty Labels: Transparency and Authenticity of the Labels of Ceylon Cinnamon. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0260474"},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"European Food Safety Authority (EFSA) (2008). Coumarin in Flavourings and Other Food Ingredients with Flavouring Properties-Scientific Opinion of the Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with Food (AFC). EFSA J., 6, 793.","DOI":"10.2903\/j.efsa.2008.793"},{"key":"ref_126","unstructured":"Federal Institute for Risk Assessment (2006). Consumers, Who Eat A Lot of Cinnamon, Currently Have an Overly High Exposure to Coumarin. BfR Health Assess, 43, 1\u201313."},{"key":"ref_127","unstructured":"Federal Institute for Risk Assessment (2006). High Daily Intakes of Cinnamon: Health Risk Cannot Be Ruled Out. BfR Health Assess, 44, 1\u201315."},{"key":"ref_128","unstructured":"(2022, October 20). Available online: https:\/\/www.theguardian.com\/world\/2013\/dec\/20\/cinnamon-intake-food-argument-denmark."},{"key":"ref_129","first-page":"EM6D","article-title":"Cinnamon rolls triggered anaphylactic reaction. The genesis could be wheat-dependent exercise-induced anaphylaxis","volume":"114","author":"Hiller","year":"2017","journal-title":"Lakartidningen"},{"key":"ref_130","unstructured":"EC (2002). Directive 2002\/46\/EC of the European Parliament and of the Council of 10 June 2002 on the Approximation of the Laws of the Member States Relating to Food Supplements. Off. J. Eur. Comm., L183, 51\u201357."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0924-2244(00)88944-X","article-title":"The Nutraceutical Revolution: Its Impact on Food Industry R&D","volume":"6","author":"DeFelice","year":"1995","journal-title":"Trends Food Sci. Technol."},{"key":"ref_132","first-page":"691","article-title":"Functional Foods and Nutraceuticals-Modern Approach to Food Science","volume":"20","author":"Sohaimy","year":"2012","journal-title":"World Appl. Sci. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/bcp.13496","article-title":"Nutraceuticals: Opening the Debate for a Regulatory Framework: Nutraceutical Regulatory Framework","volume":"84","author":"Santini","year":"2018","journal-title":"Br. J. Clin. Pharmacol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2131\/jts.46.371","article-title":"Metabolic Activation and Deactivation of Dietary-Derived Coumarin Mediated by Cytochrome P450 Enzymes in Rat and Human Liver Preparations","volume":"46","author":"Murayama","year":"2021","journal-title":"J. Toxicol. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"525","DOI":"10.2131\/jts.46.525","article-title":"Roles of Human Cytochrome P450 1A2 in Coumarin 3,4-Epoxidation Mediated by Untreated Hepatocytes and by Those Metabolically Inactivated with Furafylline in Previously Transplanted Chimeric Mice","volume":"46","author":"Miura","year":"2021","journal-title":"J. Toxicol. Sci."},{"key":"ref_136","first-page":"1107","article-title":"Determination of Genotypes of Human Aldehyde Dehydrogenase ALDH2 Locus","volume":"35","author":"Yoshida","year":"1983","journal-title":"Am. J. Hum. Genet."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.2174\/1381612824666180410091511","article-title":"Cytochrome P450s and Alcoholic Liver Disease","volume":"24","author":"Lu","year":"2018","journal-title":"Curr. Pharm. Des."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/toxsci\/kfaa048","article-title":"A Next-Generation Risk Assessment Case Study for Coumarin in Cosmetic Products","volume":"176","author":"Baltazar","year":"2020","journal-title":"Toxicol. Sci."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/24\/9063\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:44:12Z","timestamp":1760147052000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/27\/24\/9063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,19]]},"references-count":139,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["molecules27249063"],"URL":"https:\/\/doi.org\/10.3390\/molecules27249063","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,19]]}}}